GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 13051 - 13100 of 39437 in total
PDB ID UniProt ID Title Descriptor ▼
7LAG P05164 CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH Compound-14 AKA 7-({1-[(3-phenoxyphenyl)methyl]-1H-pyrazol-4-yl}methyl)-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine
7LF5 Q6MZV7 Structure of Hyperglycosylated Human IgG1 Fc (Fc267)
7LF9 Q6MZV7 Structure of Hyperglycosylated Human IgG1 Fc (Fc329)
7LQL O67854 Crystal structure of the R375D mutant of LeuT
7LRT P0DTC2 Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
7LRT 7LRT Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain
7LSA A0A2N0UU23 Ruminococcus bromii Amy12 with maltoheptaose
7LWD P31645 Cryo-EM structure of the wild-type human serotonin transporter complexed with vilazodone, imipramine and 15B8 Fab
7LWD 7LWD Cryo-EM structure of the wild-type human serotonin transporter complexed with vilazodone, imipramine and 15B8 Fab
7LWK P0DTC2 Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation
7LWQ P0DTC2 Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and SD2 subdomain of one protomer
7LWW P0DTC2 Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D614G-K417N-E484K-N501Y)
7M3F P41180 Asymmetric Activation of the Calcium Sensing Receptor Homodimer
7MEQ O15393 Crystal structure of human TMPRSS2 in complex with Nafamostat
7MG5 P02866 Concanavalin A bound to a DNA glycoconjugate, Man-ATAT
7MGB P02866 Concanavalin A bound to a DNA glycoconjugate, A(Man-T)AT
7MIX Q00975 Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution
7MIX P05484 Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution
7MIX P54284 Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution
7MIX P54289 Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution
7MM0 P0DTC2 Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
7MM0 7MM0 Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain
7MPG M1E1E4 Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14
7MPG A0A0X8XQD7 Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14
7MPG 7MPG Cryo-EM structure of Prefusion-stabilized RSV F (DS-Cav1) in complex with Fab AM14
7MTD P0DTC2 Structure of aged SARS-CoV-2 S2P spike at pH 7.4
7MY3 P0DTC2 CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
7MY3 7MY3 CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
5V52 Q495A1 Structure of TIGIT bound to nectin-2 (CD112)
5V52 Q92692 Structure of TIGIT bound to nectin-2 (CD112)
5V56 Q99835 2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114
5V56 P00323 2.9A XFEL structure of the multi-domain human smoothened receptor (with E194M mutation) in complex with TC114
5V5X Q91XX3 Protocadherin gammaB7 EC3-6 cis-dimer structure
5V6F Q9KTH2 Crystal Structure of the Second beta-Prism Domain of RbmC from V. cholerae bound to Mannotriose
5V6K Q9KTH2 Crystal Structure of the Second beta-Prism Domain of RbmC from V. cholerae Bound to N-acetylglucosaminyl-beta-1,2-mannose
5V6N Q7NDN8 Crystal Structure of the highly open channel-stabilized mutant C27S + K33C + I9'A + N21'C of GLIC under reducing conditions.
5V6O Q7NDN8 Crystal Structure of the highly open channel-stabilized mutant G-2'I + I9'A of GLIC
5V6Y P0AEY0 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant
5V6Y Q16602 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant
5V6Y O60894 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant
5V6Y P35318 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant
5V7J Q2N0S6 Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22.
5V7J 5V7J Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env Trimer with Four Glycans (N197, N276, N362, and N462) removed in Complex with Neutralizing Antibodies 3H+109L and 35O22.
5V7N Q92LZ4 Crystal structure of NADPH-dependent glyoxylate/hydroxypyruvate reductase SMc04462 (SmGhrB) from Sinorhizobium meliloti in complex with NADP and 2-Keto-D-gluconic acid
5V8K Q1MX24 Homodimeric reaction center of H. modesticaldum
5V8K B0TAT4 Homodimeric reaction center of H. modesticaldum
5VF2 5VF2 scFv 2D10 re-refined as a complex with trehalose replacing the original alpha-1,6-mannobiose
5VGJ 5VGJ Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated from Donor N90, bound to a scaffolded WITO V1V2 domain
5VGP Q6PYX1 Fc fragment of human IgG1 antibody, from NIST mAb
5VH5 5VH5 Crystal Structure of Fc fragment of anti-TNFa antibody infliximab

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024